StartupsFinSMEsabout 2 hours ago
Biograil Raises 20 Million Euro
1 min read
Copenhagen-based Biograil raised 20 million euros in funding from backers including Verve Ventures and Eli Lilly. The company plans to use the capital for Phase 1 clinical testing of its BIONDD technology and establishing a manufacturing GMP process.
Level
Hype check
Tap to vote and see what everyone thinks.